James sits down with Chris Koddermann of the International Therapeutic Psilocybin Rescheduling Initiative, or ITPRI, to discuss their new campaign to reform psilocybin laws on the world stage.
Christopher Koddermann is a Swiss-based government affairs, public policy and communications specialist with extensive experience advising clients operating in complex, highly regulated, multi-stakeholder industries. With over 20 years’ experience in politics and public affairs, Christopher has advised and represented clients on a broad range of national and global regulatory issues, including in relation to WHO proceedings.
Prior to launching his public affairs business, Koddermann Public Affairs, in 2018, Christopher held senior global government affairs and communications leadership roles in the corporate sector. A lawyer by training, he spent the early part of his career working as a political and policy advisor to various Canadian federal and provincial cabinet Ministers.
In addition to his work with ITPRI, Chris is a member of Drug Science’s Medical Psychedelics Working Group.